Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA

FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s regulatory oversight of the products.

More from Marketing & Advertising

More from Compliance